Home > Cashflow Statement > CIPLA

CIPLA
Cashflow Statement

CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹5,224 Cr₹6,821 Cr₹5,897 Cr₹4,221 Cr₹3,675 Cr
Adjustment ₹528 Cr₹518 Cr₹641 Cr₹878 Cr₹967 Cr
Changes In working Capital ₹-225 Cr₹-665 Cr₹-806 Cr₹-559 Cr₹-177 Cr
Cash Flow after changes in Working Capital ₹5,526 Cr₹6,673 Cr₹5,731 Cr₹4,540 Cr₹4,465 Cr
Cash Flow from Operating Activities ₹3,940 Cr₹5,005 Cr₹4,134 Cr₹3,238 Cr₹3,326 Cr
Cash Flow from Investing Activities ₹-2,326 Cr₹-3,691 Cr₹-2,988 Cr₹-2,389 Cr₹-1,872 Cr
Cash Flow from Financing Activities ₹-1,234 Cr₹-1,293 Cr₹-1,200 Cr₹-958 Cr₹-1,600 Cr
Net Cash Inflow / Outflow ₹380 Cr₹21 Cr₹-55 Cr₹-109 Cr₹-146 Cr
Opening Cash & Cash Equivalents ₹543 Cr₹512 Cr₹561 Cr₹658 Cr₹790 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹93 Cr₹9.26 Cr₹5.56 Cr₹12 Cr₹13 Cr
Closing Cash & Cash Equivalent ₹1,015 Cr₹543 Cr₹512 Cr₹561 Cr₹658 Cr

Compare Cashflow Statement of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹114,327.9 Cr 3.1% 1% -11.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,104.0 Cr 3.5% -1.5% 9% Stock Analytics
DIVIS LABORATORIES ₹180,119.0 Cr 1.1% -1.1% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,871.0 Cr -0.2% -0.3% 35% Stock Analytics
DR REDDYS LABORATORIES ₹107,761.0 Cr 1.1% -2.1% -5.6% Stock Analytics
MANKIND PHARMA ₹104,779.0 Cr 7.7% 0.9% 2.1% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

3.1%

1%

-11.3%

SENSEX

1.1%

2.4%

-5%


You may also like the below Video Courses